Ignite Creation Date:
2025-12-24 @ 9:26 PM
Ignite Modification Date:
2026-02-27 @ 10:33 AM
Study NCT ID:
NCT00557232
Status:
COMPLETED
Last Update Posted:
2011-11-29
First Post:
2007-11-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intraocular Bevacizumab (Avastin) for Rubeosis Iridis
Sponsor:
Instituto de Olhos de Goiania
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
JN-01-2007-ARVO
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None